3 ms·
This bothers me much less than other examples of china's ip theft. The research still gets done. Patients still reap the benefits, researchers publish as usual
by yummypaint 7y ago
This bothers me much less than other examples of china's ip theft. The research still gets done. Patients still reap the benefits, researchers publish as usual. Having the data stolen can only increase the probability of applications being developed. This is the whole point of publishing research anyway. The rent seekers who run pharma companies may lose money, but i just cant make myself care.
- sushid 7y agoI agree that the net effect for the world might be nearly equal but it’s still inherently unfair for the US and those who attempted to conduct the research in a US institution. You’re discounting the loss or setback of career for the US based researchers.